ROIVAINEN

Our group is based in Turku PET Centre, University of Turku and Turku University Hospital. Our research focuses on developing radiopharmaceuticals for the PET imaging of various inflammatory diseases. (Roivainen and Saraste Group members with principle investigators : Prof. Anne Roivainen (middle left) and Prof. Antti Saraste (next to Anne)... However, more specific markers than the currently used glucose analogue, fluorodeoxyglucose 18F-FDG, are needed to assess inflammation and its consequences in different pathologies. Aims of the present study are pre-clinical evaluation of new targeted probes and techniques for molecular imaging of inflammation. Based on previous success, our main target is vascular adhesion protein 1 (VAP-1) that mediates leukocyte traffic into inflamed site(s) and assessment of its elevated expression in inflammation states.

Also known as: Roivainen & Saraste Group

Primary location: Turku Finland